This event-driven trial uses a five-component composite endpoint of heart attack, stroke, coronary revascularization, heart failure events, or death from any cause
Semaglutide, a GLP-1 receptor agonist, is known for its ability to help suppress appetite and support healthy weight loss
Compounded semaglutide products may vary in formulation, potency, and safety and are not approved by the MHRA or other regulatory authorities in the same way as branded, licensed medicines
Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here:
GHRP-6 and Hexarelin are earlier ghrelin-receptor agonists that act on the same receptor as Ipamorelin but trigger broader endocrine responses, including cortisol, prolactin, and ACTH elevations, which limits their usefulness as clean ghrelin-pathway reference tools
But this barrier has already proven porous: Rybelsus, Novo Nordisks first attempt at delivering semaglutide in pill form, achieved 24% sales growth in 2024 across EMEA and the Rest of the World